Skip to search formSkip to main contentSkip to account menu

CS 866

Known as: 866, CS, CS-866 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Olmesartan medoxomilolmesartan

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Pharmacological and pharmacokinetic study of olmesartan medoxomil in animal diabetic retinopathy models.
2004
2004
Protein kinase C and extracellular signal regulated kinase are involved in cardiac hypertrophy of rats with progressive renal injury
Increased cardiovascular mortality is an unresolved problem in patients with chronic renal failure. Cardiac hypertrophy is… 
2003
2003
Angiotensin II stimulates the nuclear translocation of Smad2 and induces PAI-1 mRNA in rat hepatic stellate cells.
2002
2002
CS-866, a New Angiotensin II Type 1 Receptor Antagonist, Ameliorates Glomerular Anionic Site Loss and Prevents Progression of Diabetic Nephropathy in Otsuka Long-Evans Tokushima Fatty Rats
BackgroundDiabetic nephropathy is a leading cause of end-stage renal disease in industrialized countries. Previous studies have… 
2001
2001
[Effects of CS-866, an angiotensin II receptor antagonist, in 5/6 nephrectomized spontaneously hypertensive rats].
To assess the chronic antihypertensive and renal protective effects of the specific angiotensin II receptor antagonist, CS-866… 
2001
2001
Regression by ACE inhibition of arteriosclerotic changes induced by chronic blockade of NO synthesis in rats.
We previously reported that chronic inhibition of nitric oxide (NO) synthesis with N(omega)-nitro-L-arginine methyl ester (L-NAME… 
2001
2001
Angiotensin II type-1 receptor antagonist, CS-866, reduces blood pressure without affecting glucose/insulin metabolism in cholesterol-fed rabbits.
CS-866 is an angiotensin II type-1 receptor antagonist, the effects of which on systolic blood pressure (BP) and glucose/insulin… 
2000
2000
Real-time monitoring of metabolic reactions by microdialysis in combination with tandem mass spectrometry: hydrolysis of CS-866 in vitro in human and rat plasma, livers, and small intestines.
Microdialysis combined with tandem mass spectrometry was used to monitor the rapid hydrolysis of CS-866, a new prodrug-type… 
1999
1999
Cilnidipine Improves Insulin Sensitivity in the Otsuka Long-Evans Tokushima Fatty Rat, a Model of Spontaneous NIDDM
Summary. Among the antihypertensive drugs, fast-acting Ca2+ antagonists have been reported to worsen insulin sensitivity. This… 
1998
1998
D035 CS-866 (angiotensin-II receptor antagonist): A double-blind study using ambulatory blood pressure monitoring in hypertensive patients
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)